Longevity medicine: separating science from marketing.

By Kokei Abam, RDN · Registered Dietitian Nutritionist

Published June 15, 2026 · Last reviewed June 15, 2026 · 10 min read

Longevity medicine is a branch of preventive healthcare aimed at reducing the risk of age-related disease and functional decline to extend healthy years of life. It focuses on preserving physical and cognitive function through established lifestyle and medical interventions. This guide explains supplements, medications, and biological age testing by distinguishing established evidence from emerging and early-stage claims.

What longevity medicine means

Martinović et al. (2024) defines longevity medicine as an emerging preventive discipline focused on early detection of age-related risk, personalized care, and interventions aimed at supporting healthy aging and extending healthspan.¹ It integrates advanced diagnostics, lifestyle-based prevention, and increasingly individualized medical strategies that target biological processes associated with aging and age-related disease.

Longevity vs anti-aging

Longevity medicine evaluates interventions according to clinical evidence, health outcomes, and individual risk factors, while consumer anti-aging marketing often relies on broad claims about staying young, looking younger, or slowing visible and biological signs of aging. Although research continues to explore compounds that may influence biological processes associated with aging, including agents such as curcumin discussed in a 2024 review by Izadi et al.,² the strength of evidence varies substantially across interventions, and many proposed therapies have not demonstrated meaningful effects on lifespan or healthspan in humans.

Healthspan vs lifespan

Jugran et al. (2025) defined healthspan as the period of life spent in good health, free from chronic disease, disability, or significant functional decline.³ Lifespan refers to the total number of years lived, regardless of health status. Healthspan therefore focuses on quality and function across the life course, while lifespan reflects duration alone. This article uses healthspan as its primary lens because longevity medicine is largely concerned with preserving function and reducing age-related decline, not simply extending total years lived.

What has the strongest evidence (lifestyle foundations)

The strongest evidence in longevity medicine supports lifestyle-based interventions that improve modifiable health risks and reduce the likelihood of chronic disease as the most reliable drivers of long-term health outcomes. Across clinical guidelines and preventive medicine research, these strategies form the most consistently validated foundation for maintaining health and function with age.

Metabolic health

The American Association of Clinical Endocrinology's 2025 consensus statement on obesity and adiposity-based chronic disease approaches metabolic health as more than weight management alone.⁴ It emphasizes the prevention and treatment of excess adiposity, insulin resistance, and dysglycemia as key strategies for reducing chronic disease risk, including cardiovascular complications and functional decline.

In a 2024 systematic review, Giangregorio and colleagues found that metabolic syndrome is associated with a five- to sevenfold increase in type 2 diabetes risk, an approximately threefold increase in cardiovascular disease risk, and higher all-cause mortality.⁵ The same metabolic abnormalities linked to diabetes are also linked to cardiovascular disease, organ dysfunction, and premature death, making metabolic health one of the clearest intervention targets in preventive medicine.

Cardiovascular risk

Cardiovascular risk reduction is consistently positioned among the strongest evidence-based pathways linked to longer healthspan and reduced all-cause mortality, largely because atherosclerotic cardiovascular disease remains one of the most established, modifiable drivers of premature death at population level. The 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease frames this risk reduction approach in a structured sequence: universal lifestyle modification as the foundation, formal ASCVD risk estimation to stratify absolute risk, and targeted pharmacologic therapy when indicated through clinician–patient decision-making.⁶ Within this framework, diet quality, physical activity, smoking cessation, blood pressure control, and LDL-C lowering operate as the core modifiable levers through which long-term cardiovascular and mortality risk is reduced.

Muscle and strength

Loss of strength is one of the most important drivers of reduced mobility, physical performance, falls, and loss of independence with age. Reviewing more than three decades of research, Tøien and colleagues (2025) concluded that strength training consistently improves maximal strength, power, and physical performance in older adults, with benefits observed in both healthy individuals and those living with chronic disease.⁷ Among lifestyle interventions, maintaining strength has some of the clearest evidence for preserving physical function across the lifespan.

Sleep

Sleep is increasingly recognized as a component of healthy aging rather than simply a recovery behavior. In a study of adults who reached 85 years and older, Mazzotti and colleagues (2014) found that longevity was associated with highly regular sleep-wake schedules, preservation of slow-wave sleep, and favorable metabolic markers.⁸ Although sleep alone cannot determine lifespan, the evidence suggests that consistent, high-quality sleep supports many of the biological processes linked to long-term health.

Nutrition

Nutrition is one of the foundational determinants of health across the lifespan. Reviewing the biology of aging and nutrition, Rattan and Kaur (2022) describe food, diet, and nutrition as one of the three fundamental pillars of health and survival.⁹ Their review highlights the importance of overall dietary patterns, nutrient adequacy, and long-term eating habits, while noting that no single food, supplement, or dietary trend has been shown to replace the benefits of a consistently healthy diet. For people interested in longevity, dietary quality remains far better supported than most nutrition-related marketing claims.

Evidence status at a glance

Longevity research ranges from established lifestyle interventions to emerging and experimental approaches. The table below summarizes current evidence status across key areas.

Area	Evidence tier	Note
Lifestyle, metabolic and cardiovascular risk	Strong	Reduces chronic disease risk; improves long-term health outcomes. (AACE, 2025)
Muscle, sleep, nutrition	Strong	Associated with preservation of metabolic and physical function with aging. (Rattan et al., 2022; Mazzotti et al., 2014; Tøien et al., 2025)
NAD+, NMN, NR	Emerging	May increase NAD+ biomarkers in humans; clinical outcome effects not established. (Wu et al., 2025)
Rapamycin, metformin	Under study	Mechanistic and disease-level data exist; longevity benefit in healthy populations not established. (Roark & Iffland II, 2025; Soukas et al., 2019)
Peptides	Experimental	Early-stage research; human clinical longevity outcomes not established. (FDA Drugs@FDA)
Biological age tests	Limited	Variable validation; does not predict lifespan or serve as a clinical endpoint. (Apsley et al., 2025)

Where supplements may fit

Supplements attract considerable attention in longevity discussions, but they do not currently occupy the same evidence tier as established healthspan interventions. While some compounds have been studied for their effects on aging-related pathways, the quality and consistency of the evidence vary substantially, and human outcome data remain limited for many products. As a result, supplements are generally considered adjuncts to, not replacements for, the lifestyle and risk-reduction strategies that form the foundation of healthy aging. For a detailed review of individual compounds, see our guide to evidence-based longevity supplements.

What to know about NAD+, NMN, and NR

NAD+ is a naturally occurring molecule involved in cellular energy metabolism. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors used by the body to generate NAD+. Human studies show that both compounds increase NAD+ levels, confirming a measurable effect on this biological pathway. What has not yet been established is whether these changes translate into meaningful clinical outcomes such as improved healthspan, reduced disease risk, or increased lifespan in humans. See are NAD+ supplements worth it? and NMN vs NR for deeper reviews.

Emerging medications and peptides

Rapamycin, metformin, and peptide-based therapies are among the most widely discussed interventions in longevity research. These approaches remain under active study, but they are not established longevity therapies for healthy individuals, and their potential benefits and risks continue to be evaluated.

Rapamycin (sirolimus) is an mTOR inhibitor originally developed as an immunosuppressant, with established FDA-approved indications including prevention of organ transplant rejection and treatment of tuberous sclerosis complex–related conditions. Roark & Iffland II (2025) describe growing scientific interest in its relevance to longevity research as emerging from its central role in the mTOR signaling pathway, which regulates cell growth, metabolism, and stress response.¹¹ Experimental and preclinical literature links reduced mTOR activity to biological pathways implicated in age-related disease processes, including cardiometabolic and neurodegenerative conditions. However, human clinical evidence remains insufficient to establish rapamycin as a longevity therapy, and its use in this context remains investigational and off-label.

Metformin is a widely used first-line treatment for type 2 diabetes with established glucose-lowering effects and extensive long-term clinical use. Soukas et al. (2019) describe its relevance to aging research as emerging based on observed associations with cardiometabolic and cancer-related outcomes in diabetic and at-risk populations, alongside mechanistic effects on insulin signaling, mitochondrial function, and energy metabolism.¹³ These findings have generated interest in metformin as a candidate for aging-related research; however, current evidence does not establish it as a therapy for lifespan or healthspan extension in healthy individuals. Its role in longevity research remains exploratory.

Peptides are short chains of amino acids that act as signaling molecules throughout the body, influencing processes such as metabolism, tissue repair, immune function, and cellular communication. They represent a heterogeneous and rapidly evolving class of bioactive molecules studied across metabolic, regenerative, and cellular signaling pathways. Kunjulakshmi et al. (2024) developed a curated database of experimentally validated anti-aging peptides, documenting numerous compounds with reported effects on aging-related biological processes.¹⁴ Most available evidence originates from preclinical, computational, or early translational studies. According to the Drugs@FDA database and approved product labeling, no peptide therapies are currently approved for aging, longevity, or healthspan extension indications, although some peptide-based drugs are FDA-approved for other medical uses. While interest continues to grow, the current evidence base remains insufficient to support conclusions about their effects on healthy aging or longevity in humans.

Biomarkers and biological age testing

Biomarkers of aging are measurable signals in the body that reflect how different physiological systems are functioning. These include blood-based markers such as cholesterol, blood sugar, inflammation levels, and other indicators linked to metabolism, cardiovascular health, and immune activity. Each biomarker reflects a specific aspect of physiology and not a complete view of aging.

Biological age testing goes a step further. It combines multiple biomarkers into a single score using statistical models or algorithms. The aim is to estimate how "old" the body appears biologically compared with chronological age. Biomarkers can show current health status and potential risk patterns, but they do not describe aging as a single number. Biological age tests can summarize patterns across multiple systems, but results depend on the specific markers used and the model behind the calculation.¹²

Neither biomarkers nor biological age tests can precisely predict how long a person will live or provide a fixed measure of aging. Their main value is in supporting an understanding of overall health trends, and they should be interpreted alongside clinical evaluation and established health risk factors.

Red flags in longevity marketing

Longevity claims exist on a spectrum of evidence quality. The markers below identify common ways language can extend beyond what human data currently supports.

• Guaranteed outcomes. No intervention currently proven in humans can guarantee lifespan extension or disease reversal. Claims that frame a supplement, protocol, or test as a guaranteed path to longer life exceed what the evidence supports for any intervention in this category.
• Reverse-aging language. Aging is a biological process that can be modified at the margins by established lifestyle and medical interventions. Language that promises to reverse, reset, or undo aging at the cellular level typically describes preclinical or mechanistic findings, not human clinical outcomes.
• Proprietary protocols sold without published evidence. A longevity clinic or practitioner offering a branded protocol should be able to point to peer-reviewed evidence for its components. A proprietary label is not a substitute for published data, and the absence of that evidence is a meaningful signal.
• Supplement stacking presented as a system. Combining multiple supplements into a single protocol amplifies perceived complexity without necessarily adding clinical benefit. Where individual compounds lack strong human outcome data, combining them does not strengthen the evidence base.
• Biological age scores as diagnoses. Biological age scores are research tools with variable validation across testing methods and populations. A number on a report does not constitute a clinical diagnosis, and treatment decisions should not rest on it alone.

When to talk with a clinician

Talk to your physician when your health decisions depend on personal medical information. This includes having risk factors such as high blood pressure, diabetes, or heart disease, or needing help interpreting blood test results in the context of your overall health. It also applies to prescription medicines like metformin or rapamycin, where safety, dosing, and monitoring matter. Longevity clinics and structured programs may include testing, supplements, or monitoring, but their use is optional and varies widely in evidence and scope. Clinical input helps place these approaches within standard medical risk assessment and established preventive care.

How to use the longevity section of Revitalize Med

Longevity is a rapidly evolving field that includes nutrition, exercise, preventive medicine, supplements, emerging therapies, and biological age testing. This section provides a broad, evidence-based overview to help you orient yourself before exploring specific topics in greater depth.

Dedicated guides cover areas such as NAD+ supplements, NMN vs NR, evidence-based longevity supplements, and nutrition strategies for GLP-1 medications. Each focuses on what is supported by human evidence, what remains uncertain, and where research is still developing. Longevity science continues to evolve, and content is updated as new evidence emerges.

FAQs

Can you really slow aging?

There is no proven treatment that stops or reverses aging in humans, and no intervention can guarantee a slower rate of aging. What is better supported is reducing the risk of age-related disease and preserving physical and cognitive function through sleep, nutrition, physical activity, strength, metabolic health, and cardiovascular risk management. Longevity medicine is strongest when it focuses on healthspan, not promises to extend life.

Will taking more supplements help me live longer?

Not necessarily. Supplements may have a role when there is a deficiency, a specific clinical reason, or a well-supported use case, but taking more supplements does not automatically improve longevity. For most people, supplements should be viewed as possible add-ons, not replacements for the foundations of healthy aging.

Is NMN better than NR?

There is not enough human outcome evidence to say that NMN is clearly better than NR for longevity. Both NMN and NR are NAD+ precursors, which means the body can use them to support NAD+ production. Human studies show effects on NAD+ biomarkers, but that does not prove longer lifespan, better healthspan, or disease prevention. See our full NMN vs NR comparison.

Are at-home biological age tests worth it?

They may be interesting for tracking patterns over time, but should not be treated as a diagnosis or a prediction of how long someone will live. Results can vary by test type, algorithm, and the biomarkers included. They are best interpreted as limited context alongside regular medical evaluation and established health risk factors.

Do I need a longevity clinic, or can my regular doctor help?

Many evidence-based longevity priorities can start with a regular physician, especially blood pressure, cholesterol, blood sugar, weight-related risk, sleep concerns, medication review, and preventive screening. A longevity clinic may offer additional testing or structured programs, but it is optional. The most important factor is that recommendations are evidence-based and medically appropriate for the individual.

How can I tell if a longevity claim is trustworthy?

A trustworthy longevity claim should be specific, evidence-based, and clear about limits. Be cautious with promises to reverse aging, guarantee a longer life, reset biological age, or replace standard medical care. Stronger claims should be supported by human clinical evidence, not only animal studies, lab findings, biomarkers, or testimonials.

← All articles